Back to MG Mercer Global Advisors Inc.

SMMTSMMT

Showing 5 of 19 quarters

Position history for MGMercer Global Advisors Inc.'s holdings in Summit Therapeutics Inc.

No. Mercer Global Advisors exited its SMMT (Summit Therapeutics) position in Q3 2025. Its Q2 2025 13F listed 36,452 shares worth $775,696. Mercer Global Advisors first reported SMMT in Q1 2021 and held it in 18 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$900,661

Total Shares Change

-44,809

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q3
Latest
Exited
0
-100.0%
$00.0%$21.16
0
2025-Q2
Decreased
36,452
-2.5%
$775,6960.0%$20.60
0
2025-Q1
Decreased
37,395
-16.3%
$721,3500.0%$20.32
0
2024-Q4
Decreased
44,678
-0.3%
$797,2790.0%$17.89
0
2024-Q3
Decreased
44,809
-5.2%
$900,6610.0%$20.89
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used